Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Mirati Therapeutics Posts Study Titled ‘Phase 1/1B Study in Patients With Cancer KRYSTAL 14’ To ClinicalTrials.Gov; Study Is Recruiting

https://clinicaltrials.gov/ct2/show/NCT04975256

https://clinicaltrials.gov/ct2/show/NCT04975256

Total
0
Shares